These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 26501198

  • 1. Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    Badamchi-Zadeh A, McKay PF, Holland MJ, Paes W, Brzozowski A, Lacey C, Follmann F, Tregoning JS, Shattock RJ.
    PLoS One; 2015; 10(10):e0141209. PubMed ID: 26501198
    [Abstract] [Full Text] [Related]

  • 2. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate.
    Campos M, Pal S, O'Brien TP, Taylor HR, Prendergast RA, Whittum-Hudson JA.
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1477-91. PubMed ID: 7601629
    [Abstract] [Full Text] [Related]

  • 3. Antibody signature of spontaneous clearance of Chlamydia trachomatis ocular infection and partial resistance against re-challenge in a nonhuman primate trachoma model.
    Kari L, Bakios LE, Goheen MM, Bess LN, Watkins HS, Southern TR, Song L, Whitmire WM, Olivares-Zavaleta N, Caldwell HD.
    PLoS Negl Trop Dis; 2013 Jul; 7(5):e2248. PubMed ID: 23738030
    [Abstract] [Full Text] [Related]

  • 4. Oral immunization with an anti-idiotypic antibody to the exoglycolipid antigen protects against experimental Chlamydia trachomatis infection.
    Whittum-Hudson JA, An LL, Saltzman WM, Prendergast RA, MacDonald AB.
    Nat Med; 1996 Oct; 2(10):1116-21. PubMed ID: 8837610
    [Abstract] [Full Text] [Related]

  • 5. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.
    Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD.
    J Immunol; 2009 Jun 15; 182(12):8063-70. PubMed ID: 19494332
    [Abstract] [Full Text] [Related]

  • 6. Oral immunization with chlamydial major outer membrane protein (MOMP).
    Taylor HR, Whittum-Hudson J, Schachter J, Caldwell HD, Prendergast RA.
    Invest Ophthalmol Vis Sci; 1988 Dec 15; 29(12):1847-53. PubMed ID: 3192374
    [Abstract] [Full Text] [Related]

  • 7. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
    Zheng Y, Zhao WM, Wang H, Zhou YB, Luan Y, Qi M, Cheng YZ, Tang W, Liu J, Yu H, Yu XP, Fan YJ, Yang X.
    Biochem Cell Biol; 2007 Apr 15; 85(2):218-26. PubMed ID: 17534403
    [Abstract] [Full Text] [Related]

  • 8. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S, Peterson EM, Rappuoli R, Ratti G, de la Maza LM.
    Vaccine; 2006 Feb 06; 24(6):766-75. PubMed ID: 16199110
    [Abstract] [Full Text] [Related]

  • 9. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S, Theodor I, Peterson EM, de la Maza LM.
    Infect Immun; 1997 Aug 06; 65(8):3361-9. PubMed ID: 9234798
    [Abstract] [Full Text] [Related]

  • 10. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
    Wen Z, Boddicker MA, Kaufhold RM, Khandelwal P, Durr E, Qiu P, Lucas BJ, Nahas DD, Cook JC, Touch S, Skinner JM, Espeseth AS, Przysiecki CT, Zhang L.
    BMC Microbiol; 2016 Jul 27; 16(1):165. PubMed ID: 27464881
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.
    Zhu S, Feng Y, Rao P, Xue X, Chen S, Li W, Zhu G, Zhang L.
    Appl Microbiol Biotechnol; 2014 May 27; 98(9):4107-17. PubMed ID: 24458565
    [Abstract] [Full Text] [Related]

  • 12. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H, Morrison RP, Watkins NG, Caldwell HD.
    J Exp Med; 1990 Jul 01; 172(1):203-12. PubMed ID: 1694217
    [Abstract] [Full Text] [Related]

  • 13. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
    Eko FO, Lubitz W, McMillan L, Ramey K, Moore TT, Ananaba GA, Lyn D, Black CM, Igietseme JU.
    Vaccine; 2003 Apr 02; 21(15):1694-703. PubMed ID: 12639492
    [Abstract] [Full Text] [Related]

  • 14. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
    Singh SR, Hulett K, Pillai SR, Dennis VA, Oh MK, Scissum-Gunn K.
    Vaccine; 2006 Feb 20; 24(8):1213-24. PubMed ID: 16194585
    [Abstract] [Full Text] [Related]

  • 15. An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial.
    Pollock KM, Borges ÁH, Cheeseman HM, Rosenkrands I, Schmidt KL, Søndergaard RE, Day S, Evans A, McFarlane LR, Joypooranachandran J, Amini F, Skallerup P, Dohn RB, Jensen CG, Olsen AW, Bang P, Cole T, Schronce J, Lemm NM, Kristiansen MP, Andersen PL, Dietrich J, Shattock RJ, Follmann F.
    Lancet Infect Dis; 2024 Aug 20; 24(8):829-844. PubMed ID: 38615673
    [Abstract] [Full Text] [Related]

  • 16. Chlamydial polymorphic membrane proteins: regulation, function and potential vaccine candidates.
    Vasilevsky S, Stojanov M, Greub G, Baud D.
    Virulence; 2016 Aug 20; 7(1):11-22. PubMed ID: 26580416
    [Abstract] [Full Text] [Related]

  • 17. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW, Hafner LM, Beagley KW, Timms P.
    J Reprod Immunol; 2011 Sep 20; 91(1-2):9-16. PubMed ID: 21856018
    [Abstract] [Full Text] [Related]

  • 18. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S, Theodor I, Peterson EM, de la Maza LM.
    Infect Immun; 2001 Oct 20; 69(10):6240-7. PubMed ID: 11553566
    [Abstract] [Full Text] [Related]

  • 19. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L, Cai Y, Xiong Y, Du W, Cen D, Zhang C, Song Y, Zhu S, Xue X, Zhang L.
    Oncotarget; 2017 May 16; 8(20):33241-33251. PubMed ID: 28402260
    [Abstract] [Full Text] [Related]

  • 20. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H, Parnell M, Caldwell HD.
    Vaccine; 1995 Aug 16; 13(11):1023-32. PubMed ID: 8525685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.